Logo image of OBEL.BR

ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

EBR:OBEL - Euronext Brussels - BE0003735496 - Common Stock - Currency: EUR

15.15  +0.05 (+0.33%)

Fundamental Rating

4

OBEL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 6 industry peers in the Wireless Telecommunication Services industry. While OBEL is still in line with the averages on profitability rating, there are concerns on its financial health. OBEL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year OBEL was profitable.
OBEL had a positive operating cash flow in the past year.
Each year in the past 5 years OBEL has been profitable.
In the past 5 years OBEL always reported a positive cash flow from operatings.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

OBEL has a worse Return On Assets (0.54%) than 83.33% of its industry peers.
OBEL has a Return On Equity of 2.31%. This is comparable to the rest of the industry: OBEL outperforms 50.00% of its industry peers.
OBEL has a Return On Invested Capital of 3.15%. This is in the better half of the industry: OBEL outperforms 66.67% of its industry peers.
OBEL had an Average Return On Invested Capital over the past 3 years of 4.46%. This is in line with the industry average of 6.08%.
Industry RankSector Rank
ROA 0.54%
ROE 2.31%
ROIC 3.15%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.11%, OBEL is doing worse than 83.33% of the companies in the same industry.
OBEL's Profit Margin has declined in the last couple of years.
OBEL has a worse Operating Margin (6.95%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of OBEL has grown nicely.
Looking at the Gross Margin, with a value of 67.46%, OBEL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 6.95%
PM (TTM) 1.11%
GM 67.46%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
Compared to 1 year ago, OBEL has more shares outstanding
Compared to 5 years ago, OBEL has more shares outstanding
OBEL has a better debt/assets ratio than last year.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

OBEL has an Altman-Z score of 0.94. This is a bad value and indicates that OBEL is not financially healthy and even has some risk of bankruptcy.
OBEL has a worse Altman-Z score (0.94) than 66.67% of its industry peers.
The Debt to FCF ratio of OBEL is 20.08, which is on the high side as it means it would take OBEL, 20.08 years of fcf income to pay off all of its debts.
OBEL has a Debt to FCF ratio (20.08) which is in line with its industry peers.
A Debt/Equity ratio of 2.12 is on the high side and indicates that OBEL has dependencies on debt financing.
OBEL's Debt to Equity ratio of 2.12 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 20.08
Altman-Z 0.94
ROIC/WACC0.62
WACC5.06%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

OBEL has a Current Ratio of 0.61. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.61, OBEL is doing worse than 83.33% of the companies in the same industry.
OBEL has a Quick Ratio of 0.61. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
OBEL's Quick ratio of 0.56 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.56
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48642.86% over the past year.
The Earnings Per Share has been decreasing by -9.64% on average over the past years.
Looking at the last year, OBEL shows a quite strong growth in Revenue. The Revenue has grown by 13.96% in the last year.
The Revenue has been growing by 8.26% on average over the past years. This is quite good.
EPS 1Y (TTM)48642.86%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%118.05%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%0.71%

3.2 Future

The Earnings Per Share is expected to grow by 33.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, OBEL will show a very negative growth in Revenue. The Revenue will decrease by -10.97% on average per year.
EPS Next Y55.47%
EPS Next 2Y40.71%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue Next Year1.17%
Revenue Next 2Y1.06%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.56, which means the current valuation is very expensive for OBEL.
Based on the Price/Earnings ratio, OBEL is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
OBEL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.22.
Based on the Price/Forward Earnings ratio of 18.93, the valuation of OBEL can be described as rather expensive.
OBEL's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.86, OBEL is valued at the same level.
Industry RankSector Rank
PE 44.56
Fwd PE 18.93
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaper than 83.33% of the companies in the same industry.
83.33% of the companies in the same industry are more expensive than OBEL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.57
EV/EBITDA 5.07
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OBEL's earnings are expected to grow with 33.42% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y40.71%
EPS Next 3Y33.42%

0

5. Dividend

5.1 Amount

No dividends for OBEL!.
Industry RankSector Rank
Dividend Yield N/A

ORANGE BELGIUM

EBR:OBEL (5/2/2025, 7:00:00 PM)

15.15

+0.05 (+0.33%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-07 2025-02-07/amc
Earnings (Next)07-24 2025-07-24
Inst Owners5.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.02B
Analysts73.33
Price Target18.02 (18.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-57.8%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.23%
PT rev (3m)6.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)17.18%
EPS NY rev (3m)-18.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 44.56
Fwd PE 18.93
P/S 0.51
P/FCF 9.57
P/OCF 2.03
P/B 1.06
P/tB N/A
EV/EBITDA 5.07
EPS(TTM)0.34
EY2.24%
EPS(NY)0.8
Fwd EY5.28%
FCF(TTM)1.58
FCFY10.45%
OCF(TTM)7.46
OCFY49.23%
SpS29.58
BVpS14.23
TBVpS-9.7
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.54%
ROE 2.31%
ROCE 4.2%
ROIC 3.15%
ROICexc 3.21%
ROICexgc 6.38%
OM 6.95%
PM (TTM) 1.11%
GM 67.46%
FCFM 5.35%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexcg growth 3Y-7.87%
ROICexcg growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 20.08
Debt/EBITDA 3.33
Cap/Depr 83.78%
Cap/Sales 19.86%
Interest Coverage 1.31
Cash Conversion 82.24%
Profit Quality 481.9%
Current Ratio 0.61
Quick Ratio 0.56
Altman-Z 0.94
F-Score8
WACC5.06%
ROIC/WACC0.62
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48642.86%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%118.05%
EPS Next Y55.47%
EPS Next 2Y40.71%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%0.71%
Revenue Next Year1.17%
Revenue Next 2Y1.06%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%
EBIT growth 1Y12.13%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year293.76%
EBIT Next 3Y59.56%
EBIT Next 5Y21.59%
FCF growth 1Y184.99%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y33.27%
OCF growth 3Y10.98%
OCF growth 5Y8.17%